IDSA Guidelines for Using Anti-SARS-CoV-2 Monoclonal Antibody Therapy for Prophylaxis, How Severe Bacterial Infections Develop Following SARS-CoV-2 Infection, and the WHO Research and Development Plan to Combat Endemic Pathogens Including HCV, RSV, and Dengue

95 views
November 11, 2024
Comments 0
Login to view comments. Click here to Login